HD81 - Mandated Coverage for Clinical Trials for Cancer Treatments
Executive Summary: House Bill 2404 was introduced in the 1999 Session of the General Assembly. The patron of the bill is Delegate Gladys B. Keating. The legislation, as introduced, required coverage for clinical trials for life-threatening diseases under policies, contracts, or plans delivered, issued for delivery, or renewed in Virginia on and after July 1, 1999. The bill was revised during the session and was incorporated into House Bill 871. The pertinent language in House Bill 871 requires coverage for clinical trials for treatment studies on cancer, including ovarian cancer trials. House Bill 871 was passed by the House and the Senate and was signed by the Governor. However, the Chairman of the Senate Committee on Commerce and Labor requested a review of the provision by the Special Advisory Commission on Mandated Health Insurance Benefits (Advisory Commission). The Advisory Commission held a public hearing to receive comments on the bill on June 30, 1999, in Richmond. Three speakers provided comments in support of the bill in addition to the patron, Delegate Keating. Representatives of the American Cancer Society and the Massey Cancer Center, a physician from the University of Virginia, and a cancer patient spoke in support of the bill. Written comments in support of the bill were received from the American Cancer Society, the Massey Cancer Center at the Medical College of Virginia, and a physician from the University of Virginia Cancer Center. No one spoke in opposition to the bill. The Advisory Commission concluded its review of the bill on July 28, 1999. |
Menu
Published Documents
